The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis – A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up

Targeted therapies against human epidermal growth factor receptor 2 (HER2) are associated with increased interstitial lung disease (ILD). Trastuzumab, lapatinib, pertuzumab, and trastuzumab emtansine have markedly extended HER2 breast cancer survival but current knowledge on how these HER2-targeted...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chen-Han, Jung, Chiau-Jing, Huang, Yi-Ming, Chiao, Lo, Chang, Yih-Leong, Hsieh, Song-Chou, Lin, Ching-Hung, Kuo, Yu-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669110/
https://www.ncbi.nlm.nih.gov/pubmed/34894465
http://dx.doi.org/10.1016/j.breast.2021.11.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669110/
https://www.ncbi.nlm.nih.gov/pubmed/34894465
http://dx.doi.org/10.1016/j.breast.2021.11.016

Ejemplares similares